"What we do in coronary artery disease is control the disease," he said. "We put stents in, we operate on patients, we give blood pressure-lowering agents. We use a multi-modality approach."

A pair of leading shareholders in Genzyme Biosurgery have taken to federal court their move to block the forced sale of Biosurgery stock, disclosed last month by Genzyme Corp. as part of a plan to consolidate all three divisions into a single-stock trading unit. (BioWorld Today)

CHICAGO - After a wet, blustery start to the weekend, Lake Michigan sparkled under a clear sky Sunday, dotted with sailboats pushed along by lighter breezes. It was a day the likes of which many cancer patients are privileged to enjoy too few.(BioWorld Today)

When writer Jonathan Ames remarked in print that he suffered from "infuriated bowel syndrome," the remark might have been amusing but also was full of painful meaning - especially for the legions afflicted with the condition under its more common name: inflammatory bowel disease (IBD), consisting mainly of ulcerative colitis and Crohn's disease.

Among the headliners at the upcoming meeting of the American Society of Clinical Oncology are details on the eye-opening success of Genentech Inc.'s vascular endothelial growth factor drug Avastin (bevacizumab) in Phase III trials for metastatic colorectal cancer and long-awaited word regarding scandal-plagued ImClone System Inc.'s cancer drug Erbitux. But that's hardly all.